Lüönd, Rainer M

Novartis (Switzerland) · Novartis Institutes for BioMedical Research

2 papers on CoChat

Most cited papers

Verified
The BACE‐1 inhibitor CNP520 for prevention trials in Alzheimer's disease
Neumann, U., Ufer, M., Jacobson, L. H., Rouzade‐Dominguez, M., Huledal, G., Kolly, C., Lüönd, R. M., Machauer, R., Veenstra, S. J., Hurth, K., et al. (2018) · EMBO Molecular Medicine
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 177
Verified
Inhibition of Escherichia coli porphobilinogen synthase using analogs of postulated intermediates
Jarret, C., Stauffer, F., Henz, M. E., Marty, M., Lüönd, R. M., Bobálová, J., Schürmann, P., & Neier, R. (2000) · Chemistry & Biology
Porphyrin Metabolism and DisordersPorphyrin and Phthalocyanine Chemistry
Cited by 26

Go further with a free account

Verify every reference, keep papers in a library, and ask questions across them.

Sign up - it is free